Primary peritoneal adenosarcoma with stromal overgrowth and fetal type cartilage: A case report and literature review

Journal of the Medical Association of Thailand

Volumn 88, Issue 6, 2005, Pages 849-854

  Kanngurn, Samornmas ^a   Somran, Julintorn ^b   Art Ong, Chartchai ^c   Lamlertthon, Wisut ^c   Porncharoenpong, Suchat ^c  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b NARESUAN UNIVERSITY   (Thailand)

^c BUDDHACHINARAJ HOSPITAL   (Thailand)

Author keywords

Fetal type cartilage; Mixedmesodermal tumor; Peritoneal adenosarcoma; Stromal overgrowth

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADENOSARCOMA; ADULT; BLADDER; CARTILAGE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEDICAL LITERATURE; OVARY; OVARY CARCINOMA; PERITONEUM; REVIEW; STROMA; UTERINE CERVIX; UTERINE TUBE; UTERUS;

ADENOSARCOMA; CARTILAGE; FEMALE; HUMANS; MIDDLE AGED; PERITONEAL NEOPLASMS;

EID: 22744455468     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Clement PB, Scully RE. Mullerian adenosarcoma of the uterus: a clinicopathologic analysis often cases of a distinctive type of mullerian mixed tumor. Cancer 1974; 34: 1138-49.
2. Visvalingam S, Jaworski R, Blumenthal N, Chan F. Primary pertoneal mesodermal adenosarcoma: report of a case and review of the literature. Gynecol Oncol 2001; 81: 500-5.
3. Judson PL, Temple AM, Fowler WC Jr, Novotny DB, Funkhouser WK Jr. Vaginal adenosarcoma arising from endometriosis. Gynecol Oncol 2000; 76: 123-5.
4. Ramos P, Ruiz A, Carabias E, Pinero I, Garzon A, Alvarez I. Mullerian adenosarcoma of the cervix with heterologous elements: report of a case and review of the literature. Gynecol Oncol 2002; 84: 161-6.
5. de Jonge MJ, van Dam PA, Van Marck E, Prove A, van Oosterom AT. Primary extrauterine mullerian adenosarcoma of the peritoneum. Gynecol Oncol 1995; 57: 126-30.
6. Gollard R, Kosty M, Bordin G, Wax A, Lacey C. Two unusual presentations of mullerian adenosarcoma: case reports, literature review, and treatment considerations. Gynecol Oncol 1995; 59: 412-22.
7. Clement PB, Scully RE. Extrauterine mesodermal (mullerian) adenosarcoma: a clinicopathologic analysis of five cases. Am J Clin Pathol 1978; 69: 276-83.
8. Russell P, Slavutin L, Laverty CR, Cooper-Booth J. Extrauterine mesodermal (mullerian) adenosarcoma: a case report. Pathology 1970; 11: 557-60.
9. Bard E, Bard D, Vargas-Cortes F. Extra uterine mullerian adenosarcoma: a clinicopathologic report of a case with distant metastases and a review of the literature. Gynecol Oncol 1978; 6: 261-74.
10. Kerner H, Lichtig C, Beck D. Extra uterine adenosarcoma of the peritoneal mesothelium: a clinicopathologic and electron microscopic study. Obstet Gynecol 1989; 73: 510-3.
11. Nezhat CH, Malik S, Osias J, Nezhat F, Nezhat C. Laparoscopic management of 15 patients with infiltrating endometriosis of the bladder and a case of primary intravesical endometrioid adenosarcoma. Fertil Steril 2002; 78: 872-75.
12. Liu L, Davidson S, Singh M. Mullerian adenosarcoma of vaginal arising in persistent endometriosis: report of a case and review of the literature. Gynecol Oncol 2003; 90: 486-90.
13. Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease, in Atlas of tumor pathology, third series, fascicle 3, Armed Forces Institute of Pathology, Washington DC 1992: 156-66.
14. Clement PB, Scully RE. Mullerian adenosarcoma of the uterus: a clinicopathological analysis of 100 cases with a review of the literature. Hum Pathol 1990; 21: 363-81.
15. Carvalho FM, Carvalho JP, Motta EV, Souen J. Mullerian adenosarcoma of the uterus with sarcomatous over-growth following tamoxifen treatment for breast cancer. Rev Hosp Clin Fac Med S Paulo 2000; 55: 17-20.
16. Swisher EM, Gown AM, Skelly M, Ek M, Tamimi HK, Cain JM, et al. The overexpression of epidermal growth factor receptor, HER-2/neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma. Gynecol Oncol 1996; 60: 81-8.
17. Chen Z, Hong B, Drozd-Borysiuk E, Coffin C, Albritton K. Molecular cytogenetic characterization of a case of mullerian adenosarcoma. Cancer Genet Cytogenet 2004; 148: 129-32.
18. Del Carmen MG, Lovett D, Goodman A. A case report of mullerian adenosarcoma of the uterus treated with liposomal doxorubicin. Gynecol Oncol 2003; 88: 456-8.
19. Michener C, Simon NL. Ovarian conservation in a woman of reproductive age with mullerian adenosarcoma. Gynecol Oncol 2001; 83: 89-94.
20. Krivak TC, Seidman JD, McBroom JW, MacKoul PJ, Aye LM, Rose GS. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. Gynecol Oncol 2001; 83: 89-94.
21. Amant F, Gabriel C, Moerman P, Vergote I. Immunohistochemical determination of hormone receptors in uterine adenosarcomas. Gynecol Oncol 2003; 88: 463-4.
22. Hines BJ, Porges RF, Mittal K, Muggia FM, Curtin JP. Use of medroxyprogesterone acetate in the treatment of mullerian adenosarcoma: a case report. Gynecol Oncol 2002; 85: 192-5.